Altered cytoplasmic and nuclear ADP-ribosylation levels analyzed with an improved ADP-ribose binder are a prognostic factor in renal cell carcinoma.

J Pathol Clin Res · 2023 · PMC10240151 · PMID 36999983

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Separate Kaplan–Meier analyses of the ccRCC data on TMA1 and TMA2 showed a trend for better outcome in patients with nuclear ADPR (supplementary material, Figure S6A,B ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.